Europace issues correction to semaglutide atrial remodeling rat study
The corrected paper compared semaglutide and colchicine effects on atrial remodeling in rats with reduced ejection fraction after myocardial infarction.
PR
The wire
- 01Europace published a correction dated October 1 to a rat study of differential semaglutide and colchicine effects on atrial remodeling after myocardial infarction with reduced ejection fraction.
- 02Readers citing the paper for semaglutide's atrial or arrhythmia effects should pull the corrected version before relying on it.
- 03The notice does not specify what was changed, and the underlying work remains an animal study.
From the source
Read at pubmed.ncbi.nlm.nih.govCorrection to: Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026 Oct 1
Source URL https://pubmed.ncbi.nlm.nih.gov/42837319/
